top of page
News & Events
Jun 29, 2015
BrainsWay Receives ARTG Approval for Marketing its Deep TMS Treatment for Depression in Australia
BrainsWay to Expand its Activities in Australia, Previously Focused on Research JERUSALEM, June 29, 2015. BrainsWay® Ltd. (TASE: BRIN)...
Jun 2, 2015
UCSD psychiatrist David Feifel uses Deep TMS to help Depression patient
Jay Martin, a patient who has struggled with depression for decades, describes BrainsWay® Deep TMS as a Godsend, after being treated at...
Feb 9, 2015
World Psychiatry Journal 02/2015: Multicenter double blinded randomized controlled trial results,
World Psychiatry Journal 02/2015: Multicenter double blinded randomized controlled trial results show BrainsWay Deep TMS to be...
Jan 10, 2013
BrainsWay Receives FDA Clearance
JERUSALEM, Thursday 10, 2013 BrainsWay® Ltd. (TASE: BRIN) is proud to announce that the U.S. Food and Drug Administration (“FDA”) has...
bottom of page